Acciones Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE
Acciones
CBI
IL0011042806
Holding Companies
Ventas 2022 | 370 mil 99,87 mil 92,8 mil | Ventas 2023 | 104 mil 28,07 mil 26,09 mil | Capitalización | 62,27 M 16,81 M 15,62 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -61 M -16,46 M -15,3 M | Resultado Neto 2023 | -31 M -8,37 M -7,78 M | VE / Ventas 2022 | 331 x |
Deuda neta 2022 | 23,85 M 6,44 M 5,98 M | Deuda neta 2023 | 22,4 M 6,05 M 5,62 M | VE / Ventas 2023 | 814 x |
P/E ratio 2022 |
-1,6
x | P/E ratio 2023 |
-2,01
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 34,65 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01/07/15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 67 | 09/05/03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18/11/15 |
Gad Keren
BRD | Director/Board Member | 73 | 17/02/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,41 % | 77,36 mil M | |
+64,10 % | 18,24 mil M | |
+4,61 % | 16,24 mil M | |
+7,02 % | 14,06 mil M | |
-0,04 % | 12,58 mil M | |
+7,21 % | 11,87 mil M | |
+7,38 % | 10,99 mil M | |
+33,84 % | 10,26 mil M | |
+0,04 % | 9960,17 M |